Products Affected - Description
Calcium gluconate intravenous injection, American Regent
100 mg/mL, 50 mL vials, 25 count (NDC 00517-3950-25)
100 mg/mL, 100 mL vial, 25 count (NDC 00517-3900-25)
Reason for the Shortage
- American Regent has calcium gluconate on shortage due to manufacturing delays.
- Fresenius Kabi has calcium gluconate available.
- American Regent has issued a statement that all lots of calcium gluconate may contain glass particles and filters must be used. Do not use if there are visible glass particles and filter all other product.
Calcium gluconate intravenous injection, Fresenius Kabi
100 mg/mL, 10 mL plastic vial, 25 count (NDC 63323-0311-19)
100 mg/mL, 50 mL plastic vial, 25 count (NDC 63323-0311-59)
100 mg/mL, 100 mL plastic vial, 40 count (NDC 63323-0311-66)
Estimated Resupply Dates
American Regent has calcium gluconate 100 mg/mL 50 mL and 100 mL vials on back order and the company cannot estimate a release date.
April 6, February 24, January 25 and 6, 2016; December 11 and 3, November 5, September 25, August 19, June 15, April 16, March 13, February 3, January 16, 2015; December 12, November 14, October 13, September 18, 10 and 3, August 1, July 21, June 4, May 21 and 1, March 28 and 3, February 10, January 21, 2014; December 13, October 28, September 12 and 3, August 13 and 1, July 11, June 18, May 23, April 22, 10 and 1, March 25, February 21, January 2, 2013; December 10, November 19, 2012, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins